In a Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), adults with obesity (without type 2 diabetes) who received the highest dose of retatrutide (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks
Smedler E, Louhivuori L, Romanov RA, Masini D, Dehnisch Ellstrom I, Wang C, et al
The medication plays a supporting role
Its always followed by further instruction
Simon M.-C., Strassburger K., Nowotny B., Kolb H., Nowotny P., Burkart V., et al
Skin Type Fragrance-free and suitable for all skin types Cleanses Exfoliates Brightens skin Benefits Deep Cleansing Action Effectively removes impurities with a thorough deep cleansing effect